Compass Therapeutics
Compass Therapeutics is a clinical-stage biopharmaceutical company developing proprietary antibody-based therapeutics for the treatment of cancer. Its research is grounded in understanding the tumor microenvironment, designing candidates that optimize the components required for an effective anti-tumor immune response and bridge innate and adaptive immunity. Lead clinical programs include tovecimig and CTX-8371. Surfaced as a portfolio company of GV, this is a life-sciences company profile in the API Evangelist network; it publishes a corporate and investor web presence but no public developer, API, or technical integration surface.
Compass Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Life Sciences, Biopharmaceutical, Biotechnology, and Oncology.
Compass Therapeutics’ developer surface includes support and 6 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Commercial 2
Pricing, plans, and the legal terms of use
Company 3
The organization behind the API